When Neola Medical launch the medical device Neola® for continuous lung monitoring of preterm born infants, the U.S. market will be the most important market. The company recently opened an office in Palo Alto, Silicon Valley – an important step in the market preparation work. BioStock invited Neola Medical’s CEO Hanna Sjöström to hear more about the plans. See more in the interview below (in Swedish).
Read more about the opening of an office in Silicon Valley in the press release: Press communication